Latin America offers real opportunities for medical device and IVD manufacturers, but successful market entry requires a country-specific regulatory strategy. Differences in classification, submission requirements, documentation, review timelines, and post-market obligations mean that a single regional approach rarely works.
In RegDesk’s webinar, Claudia Mayer, RegDesk’s Latin America Team Lead with over 20 years of experience, walked through key market considerations, reliance pathways, common mistakes, and how companies can coordinate activities across multiple countries.
Watch the webinar replay
Why Latin America Requires a Country-Specific Strategy
Latin America includes distinct regulatory jurisdictions, each with its own medical device registration requirements, documentation expectations, review timelines, and post-market obligations. While some countries offer reliance pathways or participate in regional harmonization efforts, manufacturers must assess the requirements that apply in each target market. An approval in one country does not automatically authorize market access across the region.
How Requirements Differ Across Key Latin American Markets
– Brazil (ANVISA): Brazil has a rigorous regulatory framework. Eligible Class III and IV devices may qualify for streamlined document review based on prior approvals from recognized authorities, but local requirements still apply. Claudia noted that reliance can support review efficiency without removing Brazilian compliance obligations.
– Mexico (COFEPRIS): Mexico offers reliance pathways for eligible devices. As Claudia explained, “Reliance is not an automatic approval process.” Local documentation, labeling, and administrative requirements still apply.
– Colombia (INVIMA): Colombia can be a strategic entry market for companies expanding into Latin America. Requirements vary by risk class, and Claudia highlighted its potential role in helping manufacturers build regional experience before entering more complex markets.
– Costa Rica (Ministry of Health): Certain Class I devices generally do not require registration before commercialization, and reliance opportunities exist for some device classes. Claudia used Costa Rica to illustrate why regulatory pathways can differ significantly even within the same region.
– Argentina (ANMAT): Argentina has a technically rigorous regulatory framework. Claudia emphasized that manufacturers need a dedicated strategy and should not assume approvals from other markets automatically translate into local market access.
Broader takeaway: Regulatory strategy should consider which markets offer the greatest business value, where reliance may be available, and how submission sequencing can optimize resources and market-entry timelines. Read our blog on 8 tips for Medical Device Market Entry into LATAM Countries.
Understanding Reliance Pathways and Their Limits
Some Latin American markets offer pathways that take approvals or assessments from recognized reference authorities into account. These mechanisms can help streamline parts of the review process, but they do not automatically eliminate national requirements.
Claudia drew a key distinction: “Convergence does not mean harmonization. Although regulators are increasingly aligning their principles and approaches, this does not mean that all requirements are identical. Complete harmonization in Latin is not yet a reality. It’s just a dream.”
Reliance should therefore be evaluated as one element of a broader market-entry strategy, rather than assumed to guarantee faster approval.
Reliance is one element of a broader strategy, not a guarantee of faster approval.
Five Common Mistakes
The webinar highlighted several mistakes that can increase regulatory risk and delay commercialization:
- Treating Latin America as one market. Each country has its own regulatory framework, requirements, and timelines.
- Launching in every market simultaneously. A phased approach can help teams prioritize resources and manage dependencies.
- Underestimating translation requirements. Language and documentation inconsistencies can lead to regulatory questions and delays.
- Overlooking post-market obligations. Renewals, change management, safety monitoring, and required notifications continue after approval.
- Selecting local partners on cost alone. Regulatory expertise, execution capacity, and market knowledge are important to long-term success.
These considerations reinforce the importance of evaluating market-entry decisions against both commercial goals and the operational capacity needed to support them.
Building a Scalable Regional Strategy
Instead of treating each submission as a standalone project, companies should build a regulatory roadmap that supports their long-term expansion goals. The result: Submission preparation becomes more efficient, product information remains consistent across countries, and teams gain visibility into timelines and upcoming obligations.
Regulatory Compliance Continues After Approval
Obtaining authorization is only one stage of the regulatory lifecycle. Manufacturers must also manage product changes, registration renewals, labeling updates, post-market surveillance, and country-specific reporting obligations.
Changes to a product, manufacturing process, software, or documentation may have different regulatory implications across markets. Teams need a clear process for assessing those changes against local requirements, determining whether notifications or approvals are needed, and coordinating implementation timelines.
Maintaining visibility into registrations, applicable requirements, and upcoming obligations helps regulatory teams manage these responsibilities as their portfolios expand.
Building a Scalable Regulatory Strategy for Latin America
A regional strategy should connect market selection, submission sequencing, regulatory intelligence, and post-market activities. Rather than managing each country as an isolated registration project, teams can establish a coordinated roadmap that identifies priority markets, evaluates potential reliance opportunities, and accounts for country-specific requirements.
Regulatory information management (RIM) software can support this work by centralizing registration information, organizing submission documentation, tracking regulatory timelines, and improving visibility across markets. RegDesk connects regulatory intelligence with global regulatory operations to help medical device and IVD teams coordinate these activities.
The objective is to build a regulatory process that supports expansion while maintaining control over local requirements and ongoing compliance.
Schedule a demo to see how RegDesk can help you expand your presence in Latin America.
